
Senior Director Access Strategy aT1D and CV&M
Scorpion Therapeutics, Convent Station, New Jersey, us, 07961
Role Summary
Senior Director US Access Strategy for aT1D and CV&M, based in Morristown, NJ or Cambridge, MA. Lead a small, high-impact team defining and executing US market access strategies for TZIELD and future assets across the aT1D and CV&M portfolio. Accountable for short- and long-term pricing, contracting, and payer engagement, and oversee Patient Support Services marketing. Prepare the organization for future indication launches and contribute to portfolio decisions with a US payer, reimbursement, and pricing perspective. Responsibilities
Own the US market access strategy for TZIELD and the aT1D & CV&M portfolio, including short- and long-term pricing, contracting, and payer engagement strategy Serve as the primary US access and pricing leader for pipeline assets and business development evaluations, shaping portfolio decisions by assessing US access feasibility, reimbursement risk, and pricing potential Provide strategic leadership and decision-shaping input into market assessments, product positioning, and target product profiles by integrating access, reimbursement, and pricing considerations early and consistently across the product lifecycle Represent the US access customer perspective within cross-functional and cross-regional commercialization teams, optimizing lifecycle performance of TZIELD and future assets Own and oversee Patient Support Services (PSS) marketing, providing strategic direction through direct team leadership and ensuring patient access, affordability, and experience strategies align with payer and institutional access objectives Lead execution of core Market Access deliverables in partnership with Global Market Access and US teams, translating strategy into tools, capabilities, and field-ready resources Engage in key account and stakeholder discussions to communicate brand/portfolio value and evolving market dynamics Provide US input into Global Value and Access deliverables, including launch readiness, contracting strategy, negotiation preparedness, and innovative access frameworks Monitor and interpret the evolving US access landscape, identifying trends, risks, and opportunities and translating insights into actionable strategy Lead, develop, and mentor a high-performing access strategy team, fostering strategic thinking, cross-functional influence, and strong execution Qualifications
Required:
BA/BS; 10+ years of experience in US market access, pricing, and reimbursement with demonstrated ownership of access strategy development and execution for specialty products Proven strategic leadership, including setting access and pricing strategy, influencing senior cross-functional stakeholders, and leading teams or senior contributors in complex, matrixed organizations Deep understanding of the US payer and institutional access landscape; ability to assess access feasibility, pricing implications, and reimbursement risk across inline assets and pipeline opportunities Preferences
Demonstrated success leading in complex, matrixed organizations; ability to influence without authority and drive alignment across Global, US, and cross-functional stakeholders Proven ability to navigate highly complex, ambiguous business challenges, translating access, pricing, and reimbursement considerations into clear strategic recommendations for senior leadership Exceptional communication and relationship-building skills, including experience presenting to and influencing senior executives, and building partnerships across functions, geographies, and levels Travel
Approximately 20% Additional Requirements
Restricted covenant to be signed and executed upon hire
#J-18808-Ljbffr
Senior Director US Access Strategy for aT1D and CV&M, based in Morristown, NJ or Cambridge, MA. Lead a small, high-impact team defining and executing US market access strategies for TZIELD and future assets across the aT1D and CV&M portfolio. Accountable for short- and long-term pricing, contracting, and payer engagement, and oversee Patient Support Services marketing. Prepare the organization for future indication launches and contribute to portfolio decisions with a US payer, reimbursement, and pricing perspective. Responsibilities
Own the US market access strategy for TZIELD and the aT1D & CV&M portfolio, including short- and long-term pricing, contracting, and payer engagement strategy Serve as the primary US access and pricing leader for pipeline assets and business development evaluations, shaping portfolio decisions by assessing US access feasibility, reimbursement risk, and pricing potential Provide strategic leadership and decision-shaping input into market assessments, product positioning, and target product profiles by integrating access, reimbursement, and pricing considerations early and consistently across the product lifecycle Represent the US access customer perspective within cross-functional and cross-regional commercialization teams, optimizing lifecycle performance of TZIELD and future assets Own and oversee Patient Support Services (PSS) marketing, providing strategic direction through direct team leadership and ensuring patient access, affordability, and experience strategies align with payer and institutional access objectives Lead execution of core Market Access deliverables in partnership with Global Market Access and US teams, translating strategy into tools, capabilities, and field-ready resources Engage in key account and stakeholder discussions to communicate brand/portfolio value and evolving market dynamics Provide US input into Global Value and Access deliverables, including launch readiness, contracting strategy, negotiation preparedness, and innovative access frameworks Monitor and interpret the evolving US access landscape, identifying trends, risks, and opportunities and translating insights into actionable strategy Lead, develop, and mentor a high-performing access strategy team, fostering strategic thinking, cross-functional influence, and strong execution Qualifications
Required:
BA/BS; 10+ years of experience in US market access, pricing, and reimbursement with demonstrated ownership of access strategy development and execution for specialty products Proven strategic leadership, including setting access and pricing strategy, influencing senior cross-functional stakeholders, and leading teams or senior contributors in complex, matrixed organizations Deep understanding of the US payer and institutional access landscape; ability to assess access feasibility, pricing implications, and reimbursement risk across inline assets and pipeline opportunities Preferences
Demonstrated success leading in complex, matrixed organizations; ability to influence without authority and drive alignment across Global, US, and cross-functional stakeholders Proven ability to navigate highly complex, ambiguous business challenges, translating access, pricing, and reimbursement considerations into clear strategic recommendations for senior leadership Exceptional communication and relationship-building skills, including experience presenting to and influencing senior executives, and building partnerships across functions, geographies, and levels Travel
Approximately 20% Additional Requirements
Restricted covenant to be signed and executed upon hire
#J-18808-Ljbffr